Naivi walks through the symptoms she noticed, the fears she had going in and the results she saw over her first 14 days on tirzepatide.
Recap by typeshit. Full story at Naivi’s GLP1 Journey.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
18:51
A doctor walks through four of the most talked about weight loss drugs in one overview, covering the big names people ask about most.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
A fresh warning points to more people ending up in hospital after taking peptides that aren't approved. Tap through for who issued it.
Some users say they spend $110 to $300 a month on fiber, collagen and electrolytes to manage side effects. A Stanford doctor warns buyers often can't tell what the products contain.
Loading…